What’s next to meet public health needs? Find out at the launch of the 2019 #gfinder report #fundglobalhealth Policy Cures Research

Could we see universal regulations of NTD treatments and products in the future? #fundglobalhealth Policy Cures Research

We've launched the largest ever #Lassafever study in West Africa to provide a more accurate assessment on the disease burden in the region🌍 Up to 23,000 participants will take part in Benin 🇧🇯, Guinea🇬🇳, Liberia🇱🇷, Sierra Leone 🇸🇱 and Nigeria🇳🇬 bit.ly/3xc1kmX

As we celebrate World Hepatitis Day, we're reminded that more solutions are needed to eliminate hepatitis as a public health threat by 2030 🌏 Check out the orgs supporting R&D for Hep B & LMIC-focused R&D for Hep C in 2019: bit.ly/3iWvN3r

Nipah virus is one of the deadliest pathogens known to infect humans. We’re working with University Malaya 🇲🇾 to get a better understanding of long-term immunity in those who have survived the disease. cepi.net/news_cepi/cepi…

Recent highlights at MMV: 🏁 Positive results from the largest real-life study of pyronaridine-artesunate 🔬New partnership to eliminate P. vivax malaria 📈Launch of the Annual Report 2020 For opportunities, subscribe to MMV's e-news: mmv.org/subscribe

Remarkable effectiveness of typhoid conjugate vaccine among children in Pakistan. 95% against culture-confirmed disease!! And 97% against XDR S. Typhi. #vaccineswork. #takeontyphoid. thelancet.com/journals/langl…

Pricing agreement brings #HIV drug darunavir within reach of LMICs: bit.ly/3j0ln2J #GlobalHealth

#Schistosomiasis research is critical to achieve World Health Organization (WHO) #NTDroadmap2030 targets & leave no one behind. Join Royal Society of Tropical Medicine and Hygiene and LondonNTDResearch to discuss emerging research on morbidity hotspots, genital schistosomiasis and schistosomiasis in pregnant women. #beatNTDs bit.ly/3xwj4db